Karel Kopicka
Nuclear Physics Institute, Czech Academy of Sciences, Rez
WHAT IS A RADIOPHARMACEUTICAL?
Radioactive product fulfilling all pharmaceutical requirements and intended for in vivo administration in humans with special purpose to carry out diagnostic or therapeutic procedure
REQUIREMENTS TO BE MET BY RADIOPHARMACEUTICALS
CARRIER + RADIONUCLIDE
Carrier: provides for the affinity to a special body tissue
Radionuclide: intended to the purpose of detection only (diagnostics) or interaction with the tissue (therapeutics)
Example of a diagnostic radiopharmaceutical
123I - hippurate: thanks to its elimination from the body via renal tubular excretion, it is accumulated in kidneys, therefore the function of kidneys may be monitored and the kidneys may be visualised
Example of a therapeutic radiopharmaceutical
131I - sodium iodide: copies the natural metabolism of I" ions and accumulates in the thyroid gland; thanks to heavy accumulation in the target tissue and high LET of the beta particles in the tissue, the hyperplasia or cancer cells of the thyroid gland may be destroyed
SOURCES OF RADIONUCLIDES
• Naturally occurring radionuclides
• Radionuclides produced by reactor:
- by irradiation
- products of uranium fission
• Radionuclides produced by cyclotron
• Generator radionuclides
SPECIAL CONDITIONS FOR PRODUCTION OF RADIOACTIVE DRUGS
• Special areas under closure, fulfilling the demands for work with radionuclides and drug production
• Special equipment
• Special procedures
• Specially trained team
SPECIAL AREAS FOR RADIOPHARMACEUTICAL PRODUCTION
SPECIAL EQUIPMENT
| Radionuclide and its source | Type of decay | Half life | Energy (MeV) | Use |
| 131 I (reactor, fission products) | b- | 8.05 d | b-0.61 (87%), g 0.364 (82%) | Diagnostics, therapeutics (in vivo) |
| 125 I (reactor) | K | 57.4 d | 0.035 (100%) | In vitro |
| 123 I (cyclotron) | K | 13 h | 0.159 (100%) | Replacement of 131 I |
| 124 I (cyclotron) | b+ (28%) K (72%) | 4.2 d | 0.511 |
PET? |
EXAMPLES OF IODINE RADIOPHARMACEUTICALS
| 131 I - Iortho-iodo-hippurate | Diagnostics — isotope nephrography, renal scintigraphy |
| 131 I - meta-iodo-benzylguanidine | Therapy - feochromocytoma, neuroblastoma |
| 125 I - ortho-iodo-hippurate | Diagnostics - isotope nephrography of children |
| 125 I - labelled compounds for RIA | In vitro diagnostics |
| 123 I - meta-iodo-benzylguanidine | Diagnostics - feochromocytoma, neuroblastoma |
| 124 I - ? | Theoretical possibility of PET-examination of various tissues (so far not used with this radionuclide) |
THE IMPORTANCE OF TECHNEGIUM 99mTc IN NUCLEAR MEDICINE
| Radio-nuclide | Radio-pharmaceutical | Half-life | g -energy (MeV) | Use |
| 67Ga | 67Ga-citrate | 77.9 h | 0.092 (62%) | Diagnostics of inflammation sites / tumors |
| 81m Kr | Generator
81Rb/81mKr |
Rb 4.7 h
Kr 13 s |
0.190 (100%) | Lung ventilation |
| 111In | 111InCl | 2,81 d | 0,247, 0.173 | Labelling of blood elements, sometimes substitution of 99mTc |
| 123I | 123I - ortho-iodo-hippurate | 13 h | 0.159 (100%) | Diagnostics of kidney |
| 123I | 123I - meta-iodo-benzylguanidine |
|
Diagnostics of feochromocytoma, neuroblastoma | |
| 201Tl | 201Tl chloride | 72 h | 0.167, 0.135 | Heart diagnostics |
| 18F | 18F - -fluor-deoxy-glucose | 1.87h | 0.511 | Diagnostics of brain, heart |
QUALITY ASSURANCE AND QUALITY CONTROL OF RADIOPHARMACEUTICALS
Quality assurance: Good Manufacturing Practice + Quality Control
Identity check :- half-life measurement
-various checks of the carrier
- chemical purity
- special checks (sterility, apyrogenity)
EXAMPLE OF MANUFACTURING SCHEDULE - 81Rb/81mKr
generators
| Monday & Thursday morning | Preparation of the target &
documentation
Order deadline |
| 5,30 -7,30 p.m. | Irradiation |
| 7,45 - 8,30 p.m. | Target processing, production of 81Rb |
| 8,30-10,30 p.m. | Production of generators |
| 10,30 p.m. - 0,30 a.m. | Quality control |
| 0,30-2,30 a.m. | Packaging of generators |
| 4,45 a.m. | Transport to the customers |
| Tuesday, Friday 8,00 a.m. | Use of the generators in hospitals |
ASPECTS OF PRODUCTION OF CYCLOTRON RADIOPHARMACEUTICALS
• Target technique
• Technology of radionuclide production
• Carrier labelling
• Special conditions of the production
• Aspects of quality control
• Logistics